Edeniq Names Dr. Dan Michalopoulos as New Vice President of Technology Strategic addition of business and chemicals expert signifies commitment to advancing optimization solutions for the sugar based economy
VISALIA, Calif., Jan. 24, 2013 /PRNewswire/ -- Edeniq, Inc., a biomaterials and sustainable fuels company, today announced Dr. Dan Michalopoulos as a key new addition to the company's core technology team. Dr. Michalopoulos brings over 20 years of experience in both business and academia across chemical technology and alternative fuels sectors to his new role at Edeniq.
Most recently Dr. Michalopoulos served as Director of Technology at Ineos Bio, where he was responsible for successfully leading a multidisciplinary team of engineers and scientists in designing an ethanol manufacturing process that couples biomass gasification with anaerobic fermentation. Dr. Michalopoulos earned his BS and PhD degrees in chemistry from Lowell Technological Institute and Colorado State University, respectively, and served as a Postdoctoral Research Associate at Rice University.
"We're excited to welcome Dr. Michalopoulos to our team given his intense focus on commercialization, from a track record of bringing products and processes to market, an emphasis on managing the critical engineering-science interface, and his significant background in business development and business unit management," said Dr. Thomas P. Griffin, Edeniq's Chief Technology Officer. "We know that Dan's addition to the Edeniq team will put us in an even stronger position going forward as we continue to deliver our innovative technology solutions to the marketplace."
Dr. Michalopoulos joins Edeniq at a critical period of growth, as the company seeks to both expand their portfolio of yield enhancing technologies and bolster operations at production facilities in California, the Midwest and Brazil. Specifically, Dr. Michalopoulos will assume a pivotal role in the continued development and deployment of Edeniq's unique enzyme strategies. He brings to bear both a wide experience base and deep fundamental chemistry knowledge to further strengthen this core expertise within Edeniq.
Dr. Michalopoulos will complement Edeniq's existing technology team, led by Dr. Griffin. In addition to his interdisciplinary breadth and R&D management depth, Edeniq will benefit from Dr. Michalopoulos' seasoned professionalism in personnel development and team management as the company continues to grow.
Edeniq integrates patented mechanical and biological processes to efficiently and cost-effectively break down plant material into sugars that become sustainable fuels and/or industrial materials. Edeniq's patent portfolio includes innovation in biological catalysts plus mechanical processes that helps meet the industry-wide challenge of taking today's plant-based resources into future markets and applications. Headquartered in Visalia, CA, with locations in Omaha, Nebraska and the state of Sao Paulo in Brazil, Edeniq is funded by such leading investors as Kleiner Perkins Caufield & Byers, Draper Fisher Jurvetson, Flint Hills Resources Renewables, The Westly Group and Cyrus Capital.
SOURCE Edeniq, Inc.